These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37086924)

  • 1. Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease.
    Ding H; Li Y; Fang M; Chen J; Liu L; Lu Z; Hou J; Luo M
    J Allergy Clin Immunol; 2023 Jun; 151(6):1622-1633.e10. PubMed ID: 37086924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in
    Matsuda-Lennikov M; Biancalana M; Zou J; Ravell JC; Zheng L; Kanellopoulou C; Jiang P; Notarangelo G; Jing H; Masutani E; Oler AJ; Olano LR; Schulz BL; Lenardo MJ
    J Biol Chem; 2019 Sep; 294(37):13638-13656. PubMed ID: 31337704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease.
    Brault J; Meis RJ; Li L; Bello E; Liu T; Sweeney CL; Koontz SM; Dowdell K; Theobald N; Lee J; Allen C; Clark AB; Ravell JC; Lenardo MJ; Dahl GA; Malech HL; De Ravin SS
    Cytotherapy; 2021 Mar; 23(3):203-210. PubMed ID: 33051095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on XMEN Disease.
    Ravell JC; Chauvin SD; He T; Lenardo M
    J Clin Immunol; 2020 Jul; 40(5):671-681. PubMed ID: 32451662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease.
    Chauvin SD; Price S; Zou J; Hunsberger S; Brofferio A; Matthews H; Similuk M; Rosenzweig SD; Su HC; Cohen JI; Lenardo MJ; Ravell JC
    J Clin Immunol; 2022 Jan; 42(1):108-118. PubMed ID: 34655400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation.
    Kauskot A; Mallebranche C; Bruneel A; Fenaille F; Solarz J; Viellard T; Feng M; Repérant C; Bordet JC; Cholet S; Denis CV; McCluskey G; Latour S; Martin E; Pellier I; Lasne D; Borgel D; Kracker S; Ziegler A; Tuffigo M; Fournier B; Miot C; Adam F
    J Thromb Haemost; 2023 Nov; 21(11):3268-3278. PubMed ID: 37207862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset neurodegeneration in XMEN disease.
    Benavides D; Ebrahim A; Ravell JC; Lenardo M; Gahl WA; Toro C
    J Neuroimmunol; 2024 Jan; 386():578251. PubMed ID: 38041964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.
    Ravell J; Chaigne-Delalande B; Lenardo M
    Curr Opin Pediatr; 2014 Dec; 26(6):713-9. PubMed ID: 25313976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of
    Rowane MJ; Stewart-Bates BC; Doll RJ; Meyerson HJ; Venglarcik JS; Callahan M; Fill L; Saab R; Ochs HD; Hostoffer RW
    Ther Adv Allergy Rhinol; 2023; 14():27534030231199675. PubMed ID: 37706151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype.
    Klinken EM; Gray PE; Pillay B; Worley L; Edwards ESJ; Payne K; Bennetts B; Hung D; Wood BA; Chan JJ; Marshall GM; Mitchell R; Uzel G; Ma CS; Tangye SG; McLean-Tooke A
    J Clin Immunol; 2020 Feb; 40(2):299-309. PubMed ID: 31865525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review].
    He TY; Xia Y; Li CG; Li CR; Qi ZX; Yang J
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):48-52. PubMed ID: 29342998
    [No Abstract]   [Full Text] [Related]  

  • 12. CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes.
    Brault J; Liu T; Bello E; Liu S; Sweeney CL; Meis RJ; Koontz S; Corsino C; Choi U; Vayssiere G; Bosticardo M; Dowdell K; Lazzarotto CR; Clark AB; Notarangelo LD; Ravell JC; Lenardo MJ; Kleinstiver BP; Tsai SQ; Wu X; Dahl GA; Malech HL; De Ravin SS
    Blood; 2021 Dec; 138(26):2768-2780. PubMed ID: 34086870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease.
    Watson CM; Nadat F; Ahmed S; Crinnion LA; O'Riordan S; Carter C; Savic S
    Genes Immun; 2022 Apr; 23(2):66-72. PubMed ID: 35264785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.
    Golloshi K; Mitchell W; Kumar D; Malik S; Parikh S; Aljudi AA; Castellino SM; Chandrakasan S
    J Clin Immunol; 2024 Jun; 44(7):153. PubMed ID: 38896122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XMEN: welcome to the glycosphere.
    Freeze HH
    J Clin Invest; 2020 Jan; 130(1):80-82. PubMed ID: 31815737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation.
    Blommaert E; Cherepanova NA; Staels F; Wilson MP; Gilmore R; Schrijvers R; Jaeken J; Foulquier F; Matthijs G
    Hum Genet; 2022 Jul; 141(7):1279-1286. PubMed ID: 35182234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in
    Blommaert E; Péanne R; Cherepanova NA; Rymen D; Staels F; Jaeken J; Race V; Keldermans L; Souche E; Corveleyn A; Sparkes R; Bhattacharya K; Devalck C; Schrijvers R; Foulquier F; Gilmore R; Matthijs G
    Proc Natl Acad Sci U S A; 2019 May; 116(20):9865-9870. PubMed ID: 31036665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: EBV-Positive Extra-Nodal Marginal Zone Lymphoma Associated With XMEN Disease Caused by a Novel Hemizygous Mutation in
    Huang X; Liu D; Gao Z; Liu C
    Front Oncol; 2021; 11():653266. PubMed ID: 33869058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.
    Li FY; Chaigne-Delalande B; Su H; Uzel G; Matthews H; Lenardo MJ
    Blood; 2014 Apr; 123(14):2148-52. PubMed ID: 24550228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.
    Ravell JC; Matsuda-Lennikov M; Chauvin SD; Zou J; Biancalana M; Deeb SJ; Price S; Su HC; Notarangelo G; Jiang P; Morawski A; Kanellopoulou C; Binder K; Mukherjee R; Anibal JT; Sellers B; Zheng L; He T; George AB; Pittaluga S; Powers A; Kleiner DE; Kapuria D; Ghany M; Hunsberger S; Cohen JI; Uzel G; Bergerson J; Wolfe L; Toro C; Gahl W; Folio LR; Matthews H; Angelus P; Chinn IK; Orange JS; Trujillo-Vargas CM; Franco JL; Orrego-Arango J; Gutiérrez-Hincapié S; Patel NC; Raymond K; Patiroglu T; Unal E; Karakukcu M; Day AG; Mehta P; Masutani E; De Ravin SS; Malech HL; Altan-Bonnet G; Rao VK; Mann M; Lenardo MJ
    J Clin Invest; 2020 Jan; 130(1):507-522. PubMed ID: 31714901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.